
Elevance Health (ELV) Stock
Large health insurer managing Medicare and Medicaid plans. Here's the price, business snapshot, and what's worth knowing about Elevance Health in November 2026.
Elevance Health, Inc (ticker: ELV) is a large-cap US health-insurance conglomerate offering managed-care plans, Medicare and Medicaid services, and a growing set of digital and value-based care solutions. With a market capitalisation of about $77.73B, the company generates revenue from premiums, care-management services and partnerships with providers. Key drivers include membership growth—especially in Medicare Advantage and Medicaid—cost-management efforts and investments in data and digital tools. Investors should note exposure to medical-cost trends, regulatory change and reimbursement pressures, which can affect margins and earnings volatility. The business has scale and diversification across commercial and government programmes, but returns are not guaranteed and share prices can fall as well as rise. This summary is for general educational purposes only and is not personalised investment advice; investors should consider their own risk tolerance, diversification needs and consult a financial adviser where appropriate.
Why It’s Moving

Elevance Health sees margin recovery and analyst upgrades driving potential upside
- Chief Financial Officer Mark Kaye stated that adjusted earnings per share are expected to grow at least 12% in 2027, building on a recently increased 2026 baseline of at least $26.75.
- Analysts have turned bullish on the stock, with notable upgrades occurring this week as market participants weigh the potential for improved profitability.
- A new survey commissioned by Elevance Health indicates strong consumer demand for AI-driven healthcare simplification, with 79% of Americans believing AI can improve their experience.

Elevance Health sees margin recovery and analyst upgrades driving potential upside
- Chief Financial Officer Mark Kaye stated that adjusted earnings per share are expected to grow at least 12% in 2027, building on a recently increased 2026 baseline of at least $26.75.
- Analysts have turned bullish on the stock, with notable upgrades occurring this week as market participants weigh the potential for improved profitability.
- A new survey commissioned by Elevance Health indicates strong consumer demand for AI-driven healthcare simplification, with 79% of Americans believing AI can improve their experience.
When is the next earnings date for ELEVANCE HEALTH INC (ELV)?
No confirmed upcoming earnings date has been announced for ELV as of the current reporting cycle. Based on the company's historical pattern of reporting approximately three months after the previous quarter, the next release is expected in late January 2027. This forthcoming report will cover financial results for the fourth quarter of fiscal year 2026. Investors should monitor official channels for the precise scheduling of this anticipated announcement.
Why You’ll Want to Watch This Stock
Membership Growth Drivers
Medicare Advantage and Medicaid enrolment trends can support revenue expansion, though membership quality and medical costs influence outcomes.
US Market Exposure
Elevance is focused on the US health ecosystem and benefits from demographic ageing, but it remains sensitive to domestic policy and regulation.
Digital Innovation Push
Investments in data and care-management tech aim to reduce costs and improve outcomes, though execution and competition present ongoing risks.